icon-    folder.gif   Conference Reports for NATAP  
 
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 13-16, 2017, Seattle WA
Back grey_arrow_rt.gif
 
 
 
Darunavir/r Use and Incident Chronic Kidney Disease in HIV-positive Persons - study found increased CKD risk with ATV but not with Darunavir - D:A:D Cohort
 
 
  Reported by JulesLevin
CROI 2017 Feb 14-16 Seattle, WA
 
L Ryom1, JD Lundgren1, P Reiss2, O Kirk1, M Law3, M Ross4, P Morlat5, CA Fux6, E Fontas7, S De Wit8,
A d’Arminio Monforte9, W El Sadr10, A Phillips11, CI Hatleberg1, C Sabin11, and A Mocroft11 for the D:A:D Study Group
1 CHIP, Dept. of Infectious Diseases Section 2100, Finsencentret, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; 2 Academic Medical Center, Dept. of Global Health and Div. of Infectious Diseases, University of Amsterdam, and HIV Monitoring Foundation,
Amsterdam, The Netherlands; 3 Kirby Institute, UNSW Sydney, Sydney, Australia; 7Dept. of Public Health, Nice University Hospital, Nice, France; 8 Div. of Infectious Diseases, Saint Pierre University Hospital, Université Libre de Bruxelles, Brussels, Belgium; 9Dipartimento di Scienze
della Salute, Clinica di Malattie Infettive e Tropicali, Azienda Ospedaliera-Polo Universitario San Paolo, Milan, Italy;10ICAP-Columbia University and Harlem Hospital, New York, USA; 11Research Dept. of Infection and Population Health, UCL, London, United Kingdom

CROI1

CROI2

CROI3

CROI4

CROI5